Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
From – Diagnostic Testing & Emerging Technologies
The combination of liquid chromatography and tandem mass spectrometry enabled the discovery of four biomarkers holding promise to become…
From – Diagnostic Testing & Emerging Technologies
One of the potential therapeutic advantages of stem cells is that they can regenerate. But, a new study, published May 11 in Nature, suggests that the longer…
From – Diagnostic Testing & Emerging Technologies
New research suggests that potential shifts might occur in diabetes-related testing, including potential increased use of…